Cell Line Development Market Size By Product [Reagents & Media, Equipment (Incubator, Centrifuge, Bioreactor, Microscope), Accessories & Consumables], By Source [Mammalian, Non-Mammalian (Insects, Amphibians)], By Cell Line [Recombinant, Hybridomas, Continuous Cell Line, Primary Cell Line], By Application [Bioproduction, Drug Discovery, Toxicity Testing, Tissue Engineering, Research] Industry Analysis Report, Regional Outlook (U.S., Canada, UK, Germany, France, Italy, Spain, Russia, China, India, Japan, South Korea, Australia, Brazil, Mexico, South Africa, Saudi Arabia), Technology Development, Competitive Landscape & Forecast, 2017 – 2024
Published Date: February 2018 | 150 Pages | Report ID: GMI429 Report Format: PDF
Cell Line Development Market size was valued over USD 2.9 Billion in 2016 and is expected to witness more than 13% CAGR from 2017 to 2024.
U.S. Cell Line Development Market, By Product, 2013 - 2024 (USD Million)
Rising prevalence of cancer and chronic disorders coupled with increasing R&D for technological advancement and favourable government policies for cell line development will boost the cell line development market size. Growing awareness towards cell line therapeutics, improving economies and coupled with mounting infrastructural development the developing countries of Asia Pacific should drive the business revenue.
Increasing demand for vaccines and monoclonal antibodies coupled with technological advancements and innovations in biologics due to patent expirations will serve to be a high impact rendering factors for the industry. Increasing demand for bioproduction from incubation till preservation and cost intensive nature should prominently intensify the global usage sin the coming years.
Mounting investment for research and development in biotechnology, increasing application of recombinant cell lines in vaccines, gene therapy, and monoclonal antibody production coupled with rise in demand for vaccines in emerging economies will boost the industry size. Presence of advanced healthcare infrastructure facilities along with increasing government initiatives will propel the business growth.
Complex regulatory landscape in developing countries may restrain the industry growth over the forecast period. Concerns regarding stem cell research and hurdles during procurement of Intellectual Property Rights for these products can further hamper the business expansion during the coming years.
Cell Line Development Market, By Product
Reagent and media segment accounted for major market share in 2016 and is forecast to witness significant growth in the coming years. Furthermore, growing use in cell culture procedures and cost-effective nature will boost the segment growth. Accessories and consumables segment is set to witness significant growth owing to increasing laboratory set ups for production of cell lines, rising academic research institutes and R&D activities.
Cell Line Development Market, By Equipment
Incubator segment held the largest market share in 2016 and will continue to be most used equipment over the forecast period. Associated factors like ability to maintain optimal temperatures, humidity, and other atmospheric conditions such as carbon dioxide levels and oxygen content for the proper growth of cell culture will boost the industry size. Centrifugation segment will witness a considerable growth in the coming years due to increasing application in cell culturing process like passaging, seeding, or harvesting and in studies of cellular activities.
Cell Line Development Market, By Source
Mammalian segment will grow at a significant rate over the forecast period pertaining to ability to express complex proteins analogous to that of human beings and increased acceptance of mammalian cell source to produce monoclonal antibodies. Increasing R&D for production complex proteins such as hormone erythropoietin in higher plants or insect cells on large-scale in fermenters and short time period as compared to mammalian cell lines will boost the non-mammalian segment growth.
Cell Line Development Market, By Cell Line
Recombinant segment held the largest market share in 2016 and will continue to grow at an extensive rate over the coming years. Increasing applications in production of biologics and other cell lines, rising demand for drug screening and toxicity testing will boost the segment growth. Increasing growth of biopharmaceuticals industry, rising research for stem cells, bio-banking, genomics will create a demand for products and thus stimulating market growth.
Cell Line Development Market, By Application
Bioproduction segment held the largest market share in 2016 and will continue to grow at an extensive rate over the forecast period due to growing biopharmaceuticals and biologics industry and success of monoclonal antibodies, peptides, therapeutic proteins, enzymes in treatment of various biological conditions. Furthermore, increasing antibiotic and vaccine production will propel the industry size.
Cell Line Development Market, By Region
U.S. cell line development market accounted for largest regional share in 2016. Presence of well-established infrastructure, launch of sophisticated innovative technologies and increasing geriatric population will fuel the business size in the country. Moreover, favourable initiatives coupled with public and private companies relating to the R&D for development of stable cell lines will fuel the industry growth.
Germany cell line development market will grow at a considerable rate over the coming years owing to presence of several international and domestic companies like Boehringer Ingelheim Biopharmaceuticals, ARTES Biotechnology and CELLCA. Growing elderly population suffering from chronic diseases, advancement in biotechnology industry, increased healthcare expenditure, favourable government initiatives and funding for R&D will further offer lucrative opportunities in the Asia Pacific region. China will witness significant growth over the forecast period due to advancement in technology for mammalian cell line development for recombinant protein production, growing genetic stability and rising production of vaccines.
Competitive Market Share
Some of the major industry players in cell line development market are GE Healthcare, The European Collection of Cell Cultures, Thermo Fisher Scientific, Sigma-Aldrich, Lonza Group, Sartorius, Samsung Biologic, WuXi AppTec, Selexis, GVK BIO, and Progenitor Cell Therapy. Major industry players emphasise on development of innovative product, mergers and acquisition, collaboration, and geographical expansion to strengthen their market position. Companies should face intense competition among themselves for industry share.
Cell Line Development Industry Background
Cell line development market is highly consolidated with presence of few big market players offering wide range of products and presence in international market. Industry players will mainly emphasis on development of innovative product over the forecast period. The industry is anticipated to experience significant expansion over next decade.
What Information does this report contain?
Why Global Market Insights?Comprehensive Research
- All-inclusive coverage
- In-depth and granular data (ex: information for 8 to 15 countries, with clients open to add to this list, in each report)
- Penetrative insights & latest trends
- Offers holistic understanding of the market
- Unique methodology
- Iterative in nature to eliminate errors
- Detailed methodology, scope, assumptions and data sources available for reference
- Committed to making a positive difference for our clients
- Given the nature of this industry, we are committed to ensure that our clients get maximum return on their investment in our services
- Every purchase comes with an option to obtain additional information:
- up to 10% of the original cost
- 45-minute analyst tele-call to obtain further clarity on the market.
- Global Market Insights, Inc. strictly adheres to PCI-DSS security norms.
- Only PCI-DSS compliant payment methods used for highest level of client data security